• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳酸氢盐转运作为胰腺癌抗肿瘤免疫的调节剂。

Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer.

机构信息

Cancer Research UK Beatson Institute, Glasgow, UK.

School of Cancer Sciences, University of Glasgow, UK.

出版信息

Mol Oncol. 2023 Apr;17(4):541-544. doi: 10.1002/1878-0261.13400. Epub 2023 Mar 4.

DOI:10.1002/1878-0261.13400
PMID:36807529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10061281/
Abstract

Bicarbonate transport is a pre-existing mechanism of pH regulation in pancreatic ductal cells. In a recent study, Cappellesso et al. demonstrated that pancreatic ductal adenocarcinoma metabolic rewiring creates an acidic environment, enhanced by bicarbonate import into cancer cells via SLC4A4. This acidity favours protumourigenic immunosuppression. Targeting SLC4A4 neutralises environmental pH and restores antitumour immunity, sensitising tumours to immune checkpoint blockade.

摘要

碳酸氢盐转运是胰腺导管细胞中 pH 调节的一种预先存在的机制。在最近的一项研究中,Cappellesso 等人证明,胰腺导管腺癌的代谢重编程产生了酸性环境,通过 SLC4A4 将碳酸氢盐导入癌细胞进一步增强了酸性环境。这种酸度有利于促进肿瘤发生的免疫抑制。靶向 SLC4A4 可使环境 pH 值中和并恢复抗肿瘤免疫,使肿瘤对免疫检查点阻断更加敏感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba5/10061281/d552558e3bb2/MOL2-17-541-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba5/10061281/d552558e3bb2/MOL2-17-541-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba5/10061281/d552558e3bb2/MOL2-17-541-g001.jpg

相似文献

1
Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer.碳酸氢盐转运作为胰腺癌抗肿瘤免疫的调节剂。
Mol Oncol. 2023 Apr;17(4):541-544. doi: 10.1002/1878-0261.13400. Epub 2023 Mar 4.
2
Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer.靶向碳酸氢盐转运蛋白 SLC4A4 克服胰腺癌的免疫抑制和免疫治疗耐药性。
Nat Cancer. 2022 Dec;3(12):1464-1483. doi: 10.1038/s43018-022-00470-2. Epub 2022 Dec 15.
3
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.白细胞介素-6和程序性死亡受体配体1抗体阻断联合疗法可降低胰腺癌小鼠模型中的肿瘤进展。
Gut. 2018 Feb;67(2):320-332. doi: 10.1136/gutjnl-2016-311585. Epub 2016 Oct 21.
4
Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer.髓系细胞是胰腺癌中PD-1/PD-L1检查点激活和免疫抑制环境建立所必需的。
Gut. 2017 Jan;66(1):124-136. doi: 10.1136/gutjnl-2016-312078. Epub 2016 Jul 8.
5
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma.免疫治疗胰腺导管腺癌的最新进展和展望。
Mol Cancer. 2020 Feb 15;19(1):32. doi: 10.1186/s12943-020-01151-3.
6
Targeting both tumour-associated CXCR2 neutrophils and CCR2 macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma.靶向肿瘤相关 CXCR2 中性粒细胞和 CCR2 巨噬细胞可破坏髓系细胞募集并改善胰腺导管腺癌的化疗反应。
Gut. 2018 Jun;67(6):1112-1123. doi: 10.1136/gutjnl-2017-313738. Epub 2017 Dec 1.
7
Advances in immunotherapy for pancreatic ductal adenocarcinoma.免疫治疗在胰腺导管腺癌中的进展。
J Hepatobiliary Pancreat Sci. 2021 May;28(5):419-430. doi: 10.1002/jhbp.944. Epub 2021 Apr 3.
8
CD200 promotes immunosuppression in the pancreatic tumor microenvironment.CD200 促进胰腺肿瘤微环境中的免疫抑制。
J Immunother Cancer. 2020 Jun;8(1). doi: 10.1136/jitc-2019-000189. Epub 2020 Jun 23.
9
Radiotherapy and CD40 Activation Separately Augment Immunity to Checkpoint Blockade in Cancer.放疗和 CD40 激活分别增强了癌症的免疫检查点阻断作用。
Cancer Res. 2018 Aug 1;78(15):4282-4291. doi: 10.1158/0008-5472.CAN-17-3821. Epub 2018 May 29.
10
Viro-immune therapy: A new strategy for treatment of pancreatic cancer.病毒免疫疗法:一种治疗胰腺癌的新策略。
World J Gastroenterol. 2016 Jan 14;22(2):748-63. doi: 10.3748/wjg.v22.i2.748.

引用本文的文献

1
Regulating Intratumoral Fungi With Hydrogels: A Novel Approach to Modulating the Tumor Microbiome for Cancer Therapy.用水凝胶调节肿瘤内真菌:一种调节肿瘤微生物群用于癌症治疗的新方法。
Cancer Med. 2025 May;14(9):e70900. doi: 10.1002/cam4.70900.
2
CircRNAs in Pancreatic Cancer: New Tools for Target Identification and Therapeutic Intervention.环状 RNA 与胰腺癌:新的靶标鉴定与治疗干预工具
Cancer Genomics Proteomics. 2024 Jul-Aug;21(4):327-349. doi: 10.21873/cgp.20451.

本文引用的文献

1
Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer.靶向碳酸氢盐转运蛋白 SLC4A4 克服胰腺癌的免疫抑制和免疫治疗耐药性。
Nat Cancer. 2022 Dec;3(12):1464-1483. doi: 10.1038/s43018-022-00470-2. Epub 2022 Dec 15.
2
LRRC15 myofibroblasts dictate the stromal setpoint to suppress tumour immunity.LRRC15 肌成纤维细胞决定了基质设定点以抑制肿瘤免疫。
Nature. 2022 Nov;611(7934):148-154. doi: 10.1038/s41586-022-05272-1. Epub 2022 Sep 28.
3
In Vivo Anticancer Activity of AZD3965: A Systematic Review.
AZD3965 的体内抗癌活性:系统评价。
Molecules. 2021 Dec 29;27(1):181. doi: 10.3390/molecules27010181.
4
Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins.基质在胰腺导管腺癌中的作用:聚焦细胞外基质蛋白的综述
Front Immunol. 2021 Apr 6;12:612271. doi: 10.3389/fimmu.2021.612271. eCollection 2021.
5
Type I collagen deletion in αSMA myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer.Ⅰ型胶原在 αSMA 肌成纤维细胞中的缺失增强了免疫抑制作用,并加速了胰腺癌的进展。
Cancer Cell. 2021 Apr 12;39(4):548-565.e6. doi: 10.1016/j.ccell.2021.02.007. Epub 2021 Mar 4.
6
Metabolic support of tumour-infiltrating regulatory T cells by lactic acid.肿瘤浸润调节性 T 细胞的乳酸代谢支持。
Nature. 2021 Mar;591(7851):645-651. doi: 10.1038/s41586-020-03045-2. Epub 2021 Feb 15.
7
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid.肿瘤源性乳酸对肿瘤相关巨噬细胞功能的极化作用。
Nature. 2014 Sep 25;513(7519):559-63. doi: 10.1038/nature13490. Epub 2014 Jul 13.
8
Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.耗竭癌相关成纤维细胞和纤维化会诱导免疫抑制,并加速胰腺癌发展,降低患者生存率。
Cancer Cell. 2014 Jun 16;25(6):719-34. doi: 10.1016/j.ccr.2014.04.005. Epub 2014 May 22.
9
Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells.靶向乳酸脱氢酶——抑制肺癌小鼠模型中的肿瘤发生和肿瘤进展,并影响肿瘤起始细胞。
Cell Metab. 2014 May 6;19(5):795-809. doi: 10.1016/j.cmet.2014.03.003. Epub 2014 Apr 10.
10
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.针对富含纤维母细胞激活蛋白(FAP)的癌相关成纤维细胞中的 CXCL12 进行靶向治疗,与抗 PD-L1 免疫疗法联合应用于胰腺癌。
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20212-7. doi: 10.1073/pnas.1320318110. Epub 2013 Nov 25.